136 related articles for article (PubMed ID: 8064701)
1. Transdermal estradiol. A potentially improved method of hormone replacement.
Judd HL
J Reprod Med; 1994 May; 39(5):343-52. PubMed ID: 8064701
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
[TBL] [Abstract][Full Text] [Related]
3. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Rozenberg S; Ylikorkala O; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
Kurtay G; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
[TBL] [Abstract][Full Text] [Related]
5. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.
O'Sullivan AJ; Crampton LJ; Freund J; Ho KK
J Clin Invest; 1998 Sep; 102(5):1035-40. PubMed ID: 9727072
[TBL] [Abstract][Full Text] [Related]
6. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
7. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
8. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
Maffei S; Del Ry S; Prontera C; Clerico A
Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
[TBL] [Abstract][Full Text] [Related]
9. The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM.
Andersson B; Mattsson LA
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):260-1. PubMed ID: 10078591
[No Abstract] [Full Text] [Related]
10. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
11. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
Corazza M; Mantovani L; Montanari A; Virgili A
J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
[TBL] [Abstract][Full Text] [Related]
12. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
13. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
14. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
15. [An efficacy and tolerance study of transdermal estrogen replacement therapy with the preparation Systen R50 (Cilag)].
Tanchev S; Moskova P
Akush Ginekol (Sofiia); 1995; 34(2):65-7. PubMed ID: 8651434
[TBL] [Abstract][Full Text] [Related]
16. Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study.
Fait T; Vrablik M; Cibula D; Masata J; Hill M; Trnkova B
Neuro Endocrinol Lett; 2006 Oct; 27(5):665-8. PubMed ID: 17159824
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
[TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy - less is often more].
Schneider HP
Zentralbl Gynakol; 2001 Sep; 123(9):546-7. PubMed ID: 11709750
[TBL] [Abstract][Full Text] [Related]
19. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
20. Transdermal estrogen and prevention of osteoporosis.
Filer WD; Filer RB
Am Fam Physician; 1994 May; 49(7):1639-44. PubMed ID: 8184798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
